Infante (Reynolds) Marie C 4
4 · ORTHOPEDIATRICS CORP · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Orthopediatrics (KIDS) Director Marie C. Infante Receives Award
What Happened
Marie C. Infante, a director of Orthopediatrics Corp (KIDS), was reported on a Form 4 to have acquired 11,436 shares on 2026-06-09 via a grant/award (transaction code A). The reported acquisition price is $0.00, indicating these shares were issued as a restricted stock award (company compensation), with no cash exchanged in the transaction.
Key Details
- Transaction date: 2026-06-09; Form 4 filed: 2026-06-10 (timely filing).
- Reported price: $0.00 (award/grant). Reported value shown as $0 for the transfer.
- Footnote: Filing notes “Includes restricted stock awards totaling 17,959 shares” (may reflect total restricted shares held or included in the reporting schedule).
- Shares owned after transaction: Not specified in the available filing details.
- Filing timeliness: The Form 4 was filed within the standard reporting window (not late).
Context
Restricted stock awards are typically compensation for directors and vest over time; they are not open-market purchases and do not represent an immediate cash investment by the insider. Such grants are common and should be viewed as part of compensation rather than a direct buy/sell signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-09+11,436→ 31,202 total
Footnotes (1)
- [F1]Includes restricted stock awards totaling 17,959 shares.